Cstone Pharmaceuticals
Headquartered in Suzhou, China, CStone Pharmaceutical (inc. 2015) develops targeted anti‑cancer drugs—PD‑L1, RET, and KIT/PDGFRA inhibitors like CEJEMLY, GAVRETO, and AYVAKIT—backed by a robust pipeline, Roche collaborations, and global expansion prospects.
Headquarters: China (CHN)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 131
- HQ: Suzhou
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.